Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Atara Biotherap
(NQ:
ATRA
)
16.07
USD
+0.18 (+1.13%)
Official Closing Price
Updated: 7:48 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,163,000
Open
15.79
Bid (Size)
15.20 (1)
Ask (Size)
16.38 (1)
Prev. Close
15.89
Today's Range
15.20 - 16.25
52wk Range
4.520 - 28.20
Shares Outstanding
43,949,486
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
March 05, 2021
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases...
From
Business Wire News Releases
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
March 01, 2021
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases...
From
Business Wire News Releases
Performance
YTD
-18.18%
-18.18%
1 Month
-17.04%
-17.04%
3 Month
-38.73%
-38.73%
6 Month
+19.39%
+19.39%
1 Year
+29.08%
+29.08%
More News
Read More
Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021
February 18, 2021
From
Business Wire News Releases
Atara Biotherapeutics Presents Key Data for Advancing the Development of Tab-cel® and ATA188 at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
February 08, 2021
From
Business Wire News Releases
Atara Biotherapeutics to Present Data at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
January 19, 2021
From
Business Wire News Releases
Atara Biotherapeutics Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annual J.P. Morgan Healthcare Conference
January 10, 2021
From
Business Wire News Releases
Atara Biotherapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 06, 2021
From
Business Wire News Releases
InvestorNewsBreaks – Atara Biotherapeutics Inc. (NASDAQ: ATRA) Secures $175M in Underwritten Public Offering
January 07, 2021
From
InvestorBrandNetwork
Atara Biotherapeutics Provides Regulatory Update for Tab-Cel® for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
January 04, 2021
From
Business Wire News Releases
Atara Biotherapeutics Inc (ATRA) Q4 2020 Earnings Call Transcript
March 02, 2021
Tags
ATRA
Market News
From
Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 27, 2021
Tags
RGLS
TTOO
Movers
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.